Navigation Links
Medivation to Host Conference Call at 8:30 a.m. Eastern Time Tomorrow to Discuss Partnering Plans for Dimebon
Date:9/2/2008

SAN FRANCISCO, Sept. 2 /PRNewswire-FirstCall/ -- Medivation, Inc. (Nasdaq: MDVN) today announced that it will hold a teleconference at 8:30 a.m. Eastern Time tomorrow, Wednesday, September 3, to discuss partnering plans for Dimebon.

Teleconference/Webcast Details

To participate in the live call on Wednesday, September 3, at 8:30 a.m. Eastern Time by telephone, please dial 877-681-3375 from the U.S. or +1-719-325-4933 internationally. Individuals interested in listening to the live call via webcast may do so by visiting http://www.medivation.com. A replay of the webcast will be available on the Company's website for 30 days.

About Medivation

Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel small molecule drugs to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their caregivers. The Company's current clinical development program includes a pivotal and confirmatory Phase 3 trial of Dimebon in Alzheimer's disease and a Phase 1-2 clinical trial of MDV3100 in patients with castration-resistant (also known as hormone-refractory) prostate cancer. Medivation recently announced that it plans to continue further development of Dimebon in patients with mild-to-moderate Huntington's disease based on the positive results seen in its Phase 2 trial. For more information, please visit us at http://www.medivation.com.


'/>"/>
SOURCE Medivation, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Medivation Announces Participation in Upcoming Conferences
2. Medivation Reports Second Quarter 2008 Financial Results and Provides Corporate Update
3. Medivation Announces Second Quarter 2008 Teleconference and Webcast on August 11, 2008
4. Medivation Announces Presentation at the BMO Capital Markets 2008 Focus on Healthcare Conference on August 5
5. Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration-Resistant Prostate Cancer Patients
6. Medivation Announces Senior Management Promotions
7. Medivation Reports Year-End 2007 Financial Results and Pipeline Progress
8. Medivation Announces Participation in Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
9. Medivation Selected as Founding Member of New NASDAQ(R) NeuroInsights(R) Neurotech Index
10. Medarex to Present at the Thomas Weisel Partners Healthcare Conference
11. Anesiva Announces Conference Call and Webcast to Discuss Updates to Corporate Strategy and Milestones
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... ... Lajollacooks4u, San Diego’s premier team building events and cooking events company, announced ... and company expansion. , This is largely due to its team building ... people. Ever since, Lajollacooks4u has seen significant demand for its services from organizations across ...
(Date:12/8/2016)... SAN DIEGO , Dec. 8, 2016 /PRNewswire/ ... presented demonstrating the role of the Breast Cancer ... stage, ER+ breast cancer are most at-risk for ... therapy. Data include results from three studies advancing ... provide information related to tumor biology and inform ...
(Date:12/8/2016)... Oregon (PRWEB) , ... December 08, 2016 , ... ... and the FrontPanel SDK that provide essential device-to-computer interconnect using USB or PCI ... not require FrontPanel support. The FOMD-ACV-A4 is a small, thin, SODIMM-style module that ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... portal. In response to client demand KbioBox developed a sophisticated “3 click” gene ... Both are accessible from KBioBox’s new website, https://www.kbiobox.com/ and powered ...
Breaking Biology Technology:
(Date:11/22/2016)... , November 22, 2016 According to the ... IRIS, Palm Print, Face, Vein, Signature, Voice), Multi-Factor), Component (Hardware and Software), ... published by MarketsandMarkets, the market is expected to grow from USD 10.74 ... CAGR of 16.79% between 2016 and 2022. ... ...
(Date:11/21/2016)...   Neurotechnology , a provider of high-precision ... that the MegaMatcher On Card fingerprint matching algorithm ... NIST Minutiae Interoperability Exchange (MINEX) III ... of the evaluation protocol. The ... fingerprint templates used to establish compliance of template ...
(Date:11/17/2016)... LONDON , Nov. 17, 2016 Global Market ... and Public Biobanks (Disease-Based Banks, Population-Based Banks and Academics) market ... Geographical analysis for Private Biobanks shows the highest Compounded Annual ... Asia-Pacific region during the analysis period 2014-2020. ... a CAGR of 9.95% followed by Europe ...
Breaking Biology News(10 mins):